Latest News for UPC
Ji'an, Jiangxi, China, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Universe Pharmaceuticals INC (NASDAQ: UPC) (“Universe Pharmaceuticals” or the “Company”), a pharmaceutical producer and distributor in China, today announced that all conditions to the implementation of its dual-class share structure have been satisfied and that its dual-class share structure will become effective on the Nasdaq Capital Market on February 13,…
NRx Pharmaceuticals (NASDAQ: NRXP - Get Free Report) and Universe Pharmaceuticals (NASDAQ: UPC - Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, risk, earnings, dividends and valuation. Profitability This table compares NRx Pharmaceuticals and
Centessa Pharmaceuticals (NASDAQ: CNTA - Get Free Report) and Universe Pharmaceuticals (NASDAQ: UPC - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, dividends, institutional ownership, risk, profitability, analyst recommendations and valuation. Risk and Volatility Centessa Pharmaceuticals has a beta
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for UPC.
U.S. House Trading
No House trades found for UPC.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.